Bruton's Tyrosine Kinase Inhibitors
DBCAT005514Pharmacologic class
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of July 28, 2021
Which targets do Bruton's Tyrosine Kinase Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account